Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Targeted therapy with imatinib: Hits and misses?
Margaret von Mehren
Cancer Epigenetics Institute
Cancer Signaling and Microenvironment (CSM)
Hematology Oncology
Research output
:
Contribution to journal
›
Editorial
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted therapy with imatinib: Hits and misses?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Combination Therapy
100%
Imatinib
100%